ScinoPharm Taiwan Ltd (1789) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.033x

Based on the latest financial reports, ScinoPharm Taiwan Ltd (1789) has a cash flow conversion efficiency ratio of 0.033x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$343.96 Million ≈ $10.84 Million USD) by net assets (NT$10.52 Billion ≈ $331.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

ScinoPharm Taiwan Ltd - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how ScinoPharm Taiwan Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read ScinoPharm Taiwan Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.

ScinoPharm Taiwan Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of ScinoPharm Taiwan Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Ningbo Tianyi Medical Appliance Co. Ltd. SHE:301097	N/A
Shanxi C&Y Pharmaceutical Group Co Ltd SHE:300254	0.092x
Fenix Outdoor International AG ST:FOI-B	0.140x
Dada Nexus Ltd NASDAQ:DADA	0.009x
Yulon Nissan Motor Co Ltd TW:2227	-0.007x
Grand Korea Leisure Co. Ltd KO:114090	0.076x
NH SPAC 8 KQ:225570	-0.014x
Addiko Bank AG VI:ADKO	N/A

Annual Cash Flow Conversion Efficiency for ScinoPharm Taiwan Ltd (2007–2025)

The table below shows the annual cash flow conversion efficiency of ScinoPharm Taiwan Ltd from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see ScinoPharm Taiwan Ltd stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	NT$10.52 Billion ≈ $331.59 Million	NT$597.11 Million ≈ $18.81 Million	0.057x	-20.47%
2024-12-31	NT$10.53 Billion ≈ $331.62 Million	NT$750.91 Million ≈ $23.66 Million	0.071x	+219.91%
2023-12-31	NT$10.36 Billion ≈ $326.54 Million	NT$231.13 Million ≈ $7.28 Million	0.022x	-69.88%
2022-12-31	NT$10.45 Billion ≈ $329.23 Million	NT$773.79 Million ≈ $24.38 Million	0.074x	+52.66%
2021-12-31	NT$10.51 Billion ≈ $331.16 Million	NT$509.82 Million ≈ $16.06 Million	0.049x	-46.03%
2020-12-31	NT$10.53 Billion ≈ $331.73 Million	NT$946.31 Million ≈ $29.81 Million	0.090x	+16.88%
2019-12-31	NT$10.26 Billion ≈ $323.24 Million	NT$788.95 Million ≈ $24.86 Million	0.077x	-34.20%
2018-12-31	NT$10.54 Billion ≈ $332.04 Million	NT$1.23 Billion ≈ $38.80 Million	0.117x	+25.28%
2017-12-31	NT$10.42 Billion ≈ $328.20 Million	NT$971.71 Million ≈ $30.61 Million	0.093x	-42.70%
2016-12-31	NT$10.23 Billion ≈ $322.23 Million	NT$1.67 Billion ≈ $52.46 Million	0.163x	+53.63%
2015-12-31	NT$9.86 Billion ≈ $310.55 Million	NT$1.04 Billion ≈ $32.91 Million	0.106x	+11.90%
2014-12-31	NT$9.38 Billion ≈ $295.53 Million	NT$888.29 Million ≈ $27.99 Million	0.095x	-2.80%
2013-12-31	NT$9.64 Billion ≈ $303.82 Million	NT$939.47 Million ≈ $29.60 Million	0.097x	-9.97%
2012-12-31	NT$9.07 Billion ≈ $285.78 Million	NT$981.55 Million ≈ $30.92 Million	0.108x	-28.44%
2011-12-31	NT$8.56 Billion ≈ $269.67 Million	NT$1.29 Billion ≈ $40.78 Million	0.151x	-35.46%
2010-12-31	NT$6.68 Billion ≈ $210.37 Million	NT$1.56 Billion ≈ $49.29 Million	0.234x	-19.27%
2009-12-31	NT$4.47 Billion ≈ $140.89 Million	NT$1.30 Billion ≈ $40.89 Million	0.290x	-29.06%
2008-12-31	NT$3.44 Billion ≈ $108.39 Million	NT$1.41 Billion ≈ $44.34 Million	0.409x	+105.43%
2007-12-31	NT$2.53 Billion ≈ $79.82 Million	NT$504.50 Million ≈ $15.89 Million	0.199x	--

About ScinoPharm Taiwan Ltd

TW:1789 Taiwan Drug Manufacturers - Specialty & Generic

Market Cap

$505.73 Million

NT$16.05 Billion TWD

Market Cap Rank

#12478 Global

#441 in Taiwan

Share Price

NT$20.30

Change (1 day)

-1.93%

52-Week Range

NT$16.35 - NT$28.25

All Time High

NT$55.57